| Datum | Källa | Rubrik | Typ | Alternativ |
|---|---|---|---|---|
| 2024-04-25 | Abliva | Abliva beslutar om en riktad emission av aktier till garanter i samband med den genomförda företrädesemissionen | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-25 | Abliva | Abliva resolves on a directed issue of shares to guarantors in connection with the completed rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-24 | Abliva | Abliva AB Publishes 2023 Annual Report | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-24 | Abliva | Abliva AB publicerar årsredovisningen för 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-22 | Abliva | Notice of Annual General Meeting of Abliva AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-22 | Abliva | Kallelse till årsstämma i Abliva AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-19 | Abliva | Abliva publishes rights issue outcome | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-19 | Abliva | Abliva offentliggör utfall i företrädesemission | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-08 | Abliva | BioStock: Abliva vill bli en nyckelspelare inom mitokondriell medicin | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-04-08 | Abliva | BioStock: Abliva's mission to become mitochondrial medicine powerhouse | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-03-27 | Abliva | Abliva offentliggör prospekt med anledning av företrädesemission som till 100 procent omfattas av tecknings- och garantiåtaganden och upptagande till handel av nyemitterade aktier | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-27 | Abliva | Abliva publishes prospectus in connection with rights issue covered to 100 per cent by subscription and guarantee undertakings and admission to trading of newly issued shares | Pressreleaser | Ladda ner | Visa Stäng |
|
Pressreleaser |
Abliva publishes prospectus in connection with rights issue covered to 100 per cent by subscription and guarantee undertakings and admission to trading of newly issued sharesTHIS PRESS RELEASE IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SWITZERLAND, THE UNITED STATES OR ANY OTHER COUNTRY WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR REGULATIONS OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE PREPARED OR REGISTERED OR REQUIRE ANY OTHER ACTIONS TO BE TAKEN, IN ADDITION TO THE REQUIREMENTS UNDER SWEDISH LAW. PLEASE SEE ”IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE. The Board of Directors in Abliva AB (Nasdaq Stockholm: ABLI) (”Abliva” or the ”Company”) has, in connection with the preferential rights issue announced on 22 February 2024, prepared a prospectus (the “Prospectus”) which today has been approved and registered by the Swedish Financial Supervisory Authority. Publication of Prospectus The rights issue in summary
The rights issue is 100 percent covered by subscription and guarantee commitments. Upon full subscription in the Rights Issue, the Company will receive approximately SEK 46 million before transaction costs which is estimated to amount to approximately SEK 6.5 million (of which up to approximately SEK 3.3 million is underwriting fees). For further information on the Rights Issue, please refer to the published prospectus. Advisors |
||||
| 2024-03-26 | Abliva | Beslut vid extra bolagsstämma i Abliva AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-26 | Abliva | Resolutions at the Extraordinary General Meeting in Abliva AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-29 | Abliva | BioStock: Ablivas vd kommenterar den föreslagna kapitalanskaffningen | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-02-29 | Abliva | BioStock: Abliva's CEO comments on the proposed capital raise | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-02-27 | Penser Future by Carnegie | Penser Future by Carnegie: Abliva - Interimdata i sommar | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-02-23 | Abliva | Abliva AB Year-End Report January – December 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-23 | Abliva | Abliva AB Bokslutskommuniké januari – december 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-22 | Abliva | Kallelse till extra bolagsstämma i Abliva AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-22 | Abliva | Notice of Extraordinary General Meeting of Abliva AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-22 | Abliva | The Board of Directors of Abliva resolves on a fully guaranteed rights issue of SEK 46 million and a directed issue of convertible bonds of SEK 42 million to prepare for the final stage of the FALCON study | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-22 | Abliva | Styrelsen för Abliva beslutar om en fullt garanterad företrädesemission om 46 MSEK och en riktad emission av konvertibler om 42 MSEK för att förbereda slutfasen av FALCON-studien med KL1333 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-12-21 | Abliva | BioStock: Abliva når mål för patientinkludering | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-12-21 | Abliva | BioStock: Abliva reaches enrollment goal | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-12-20 | Abliva | Abliva når mål för patientinkludering i Steg 1 av FALCON-studien | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-12-20 | Abliva | Abliva Reaches Patient Enrollment Goal for Wave 1 of the FALCON Study | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-12-15 | Abliva | BioStock: Abliva's CEO: "Orphan drug designation is great validation" | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-12-15 | Abliva | BioStock: Ablivas vd: "Orphan drug designation is great validation" | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-12-15 | Penser Future by Carnegie | Penser Future by Carnegie: Abliva - Huvudkonkurrent misslyckas | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-12-14 | Penser Future by Carnegie | Penser Future by Carnegie: Abliva - 4 minutes by Penser | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-12-14 | Abliva | Abliva erhåller särläkemedelsklassificering från EU-kommissionen för sin läkemedelskandidat NV354 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-12-14 | Abliva | Abliva Receives Orphan Designation from the European Commission for its Drug Candidate NV354 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-20 | Penser Future | Penser Future: Luft under vingarna - Abliva | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-11-17 | Abliva | Abliva AB Delårsrapport januari – september 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-17 | Abliva | Abliva AB Interim Report January – September 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-16 | Abliva | BioStock: Abliva tecknar globalt licensavtal för NeuroSTAT | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-11-16 | Abliva | BioStock: Abliva signs global license deal for NeuroSTAT | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-11-15 | Penser Future | Penser Future: Licensierar ut NeuroSTAT - Abliva | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-11-14 | Abliva | Abliva och Owl Therapeutics ingår licens- och samarbetsavtal för NeuroSTAT® vid traumatisk hjärnskada | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-14 | Abliva | Abliva and Owl Therapeutics enter into licensing and collaboration agreement for NeuroSTAT® in Traumatic Brain Injury | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-10-18 | Abliva | Abliva presenterar på BioStock Life Science Summit den 25 oktober | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-10-18 | Abliva | BioStock: Abliva's VP of Clinical Operations on the screening achievement | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-10-18 | Abliva | BioStock: Ablivas VP of Clinical Operations om uppnått screening-mål | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-10-11 | Abliva | Abliva Achieves Important Milestone in the Ongoing FALCON Study | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-10-11 | Abliva | Abliva når viktig milstolpe i den pågående FALCON-studien | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-19 | Abliva | BioStock:Abliva increases awareness of mitochondrial diseases | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-09-19 | Abliva | BioStock:Abliva ökar medvetenheten om mitkondriella sjukdomar | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-09-18 | Abliva | Abliva to Participate in World Mitochondrial Disease Week 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-18 | Abliva | Abliva uppmärksammar World Mitochondrial Disease Week 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-08 | Abliva | BioStock: Abliva receives FDA Fast Track designation | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-09-08 | Abliva | BioStock: Abliva erhåller FDA Fast Track-status | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-09-04 | Abliva | Abliva’s Lead Candidate KL1333 Receives FDA Fast Track Designation | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-04 | Abliva | Ablivas huvudkandidat KL1333 får Fast Track-status från FDA | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-21 | Penser Future | Penser Future: Patientrekrytering i fokus - Abliva | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-08-18 | Abliva | Abliva AB Interim Report January – June 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-18 | Abliva | Abliva AB Delårsrapport januari-juni 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-06-30 | Abliva | BioStock: First patient dosed in Abliva's Falcon study | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-06-30 | Abliva | BioStock: Första patienten doserad i Ablivas Falcon-studie | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-06-30 | Abliva | BioStock: First patient dosed in Abliva's Falcon study | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-06-30 | Abliva | BioStock: Första patienten doserad i Ablivas Falcon-studie | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-06-29 | Abliva | Abliva presenterar på UMDF Mitochondrial Medicine 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-06-29 | Abliva | Abliva presents at UMDF Mitochondrial Medicine 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-06-28 | Abliva | Abliva meddelar att första patienten doserats i FALCON-studien | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-06-28 | Abliva | Abliva announces first patient dosed in the FALCON study | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-06-14 | Abliva | BioStock: Abliva's presence is felt at Euromit | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-06-14 | Abliva | BioStock: Ablivas CMO om presentation på Euromit | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-06-12 | Abliva | Abliva presents scientific data at international conference on mitochondrial medicine | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-06-12 | Abliva | Abliva presenterar vetenskapliga data vid internationell konferens inom mitokondriell medicin | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-05-24 | Penser Future | Penser Future: Interview with Abliva - Erik Penser Bank - May 24th 2023 | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-05-24 | Penser Future | Penser Future: Tidsplan för FALCON-studien intakt - Abliva | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-05-23 | Abliva | Abliva AB Delårsrapport januari-mars 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-05-23 | Abliva | Abliva AB Interim Report January – March 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-05-05 | Abliva | Resolutions from Annual General Meeting in Abliva AB (publ) on May 5, 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-05-05 | Abliva | Beslut vid årsstämma den 5 maj 2023 i Abliva AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-05-04 | Abliva | Ändring av valberedningens förslag till Ablivas årsstämma 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-05-04 | Abliva | Amendment of the Nomination Committee's proposal for Abliva’s Annual General Meeting in 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
Kommande händelser
